G611-1853 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl]acetamide

G611-1853 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl]acetamide
G611-1853 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G611-1853
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G611-1853

Molecular Formula

C24H30N4O4 (C24 H30 N4 O4)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl]acetamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[7-methyl-3-(morpholine-4-carbonyl)-4-oxo-14-dihydro-18-naphthyridin-1-yl]acetamide

SMILES

Cc(cc1)nc(N(CC(NCCC2=CCCCC2)=O)C=C2C(N3CCOCC3)=O)c1C2=O

InChI

InChI=1S/C24H30N4O4/c1-17-7-8-19-22(30)20(24(31)27-11-13-32-14-12-27)15-28(23(19)26-17)16-21(29)25-10-9-18-5-3-2-4-6-18/h5,7-8,15H,2-4,6,9-14,16H2,1H3,(H,25,29)

InChI Key

LXCZWDNUNFXORT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27146523

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.982

Distribution Coefficient, logD

1.982

Water Solubility, LogSw

-2.88

Polar Surface Area

74.330

Acid Dissociation Constant (pKa)

15.33

Base Dissociation Constant (pKb)

-0.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

G611-1853 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G611-1853 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G611-1853?
Check Price and Availability of G611-1853, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G611-1853 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G611-1853
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G611-1853
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G611-1853 available by request